📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease. (2022)

First Author: Mills C

Attributed to: Regulation of RhoGTPase signalling at endothelial junctions and blood vessel integrity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cells11111733

PubMed Identifier: 35681428

Publication URI: http://europepmc.org/abstract/MED/35681428

Type: Journal Article/Review

Volume: 11

Parent Publication: Cells

Issue: 11

ISSN: 2073-4409